These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4355701)

  • 1. Renin, angiotensin and hypertensive vascular damage: a review.
    Giese J
    Am J Med; 1973 Sep; 55(3):315-32. PubMed ID: 4355701
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of renin and angiotensin in hypertension.
    Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Padfield PL; Semple PF; Robertson JI
    Cardiovasc Clin; 1978; 9(1):55-89. PubMed ID: 352522
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
    Laragh JH
    Am J Med; 1973 Sep; 55(3):261-74. PubMed ID: 4355699
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renin and arterial hypertension].
    Schwartz J; Bloch R; Imbs JL; Fontaine JL; Velly J
    Presse Med (1893); 1969 Feb; 77(7):237-40. PubMed ID: 4307569
    [No Abstract]   [Full Text] [Related]  

  • 5. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension.
    Beilin LJ; Goldby FS; Mohring J
    Clin Sci Mol Med; 1977 Feb; 52(2):111-7. PubMed ID: 844244
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma renin activity in hypertension.
    Oparil S
    Compr Ther; 1975 Dec; 1(8):57-64. PubMed ID: 1222561
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system.
    Schalekamp MA; Beevers DG; Briggs JD; Brown JJ; Davies DL; Fraser R; Lebel M; Lever AF; Medina A; Morton JJ; Robertson JI; Tree M
    Am J Med; 1973 Sep; 55(3):379-90. PubMed ID: 4355704
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the renin-angiotensin system contribute to the vascular lesions in renal hypertensive rats?
    Dietz R; Haebara H; Lüth B; Mast G; Nemes Z; Schömig A; Szokol M
    Clin Sci Mol Med Suppl; 1976 Dec; 3():33s-35s. PubMed ID: 1071639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood renin levels in various types of arterial hypertension. Preliminary communication.
    Januszewicz W; Baczko A; Wocial B
    Pol Med J; 1969; 8(1):1-7. PubMed ID: 4305686
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin and hypertension in childhood.
    Dillon MJ
    Arch Dis Child; 1974 Nov; 49(11):831-4. PubMed ID: 4140710
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK; Williams GH; Adams DF; Moore T; Brown C; Borucki LJ; Leung F; Bavli S; Solomon HS; Passan D; Dluhy R
    Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
    Ayers CR
    Va Med Mon (1918); 1969 Jun; 96(6):312-4. PubMed ID: 4308355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renin and sodium and the formation of vascular lesions in hypertension].
    Gavras H; Brunner HR
    Schweiz Med Wochenschr; 1974 Sep; 104(38):1301-10. PubMed ID: 4371116
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulation of the renin-angiotensin system].
    Kimlová I; Sternová H; Stredová M; Vísek V; Musil J
    Cas Lek Cesk; 1973 Apr; 112(15):470-4. PubMed ID: 4349120
    [No Abstract]   [Full Text] [Related]  

  • 16. Accelerated induction to two-kidney hypertension in rats and renin-angiotensin sensitivity.
    Skulan TW; Brousseau AC; Leonard KA
    Circ Res; 1974 Nov; 35(5):734-41. PubMed ID: 4371192
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renin-angiotensin-system and intrarenal vascular resistance].
    Ziegler M; Janzik W
    Urologe; 1968; 7(2):115-8. PubMed ID: 4298040
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin and its vasopressive action. II. Action of angiotensin in normal and hypertensive humans].
    Schwartz J; Bloch R; Desaulles F; Imbs JL
    Pathol Biol; 1967; 15(11):653-6. PubMed ID: 4292972
    [No Abstract]   [Full Text] [Related]  

  • 19. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F; Dietz R; Lüth JB; Mann JF
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():177-87. PubMed ID: 613563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypotensive effects of safflower yellow in spontaneously hypertensive rats and influence on plasma renin activity and angiotensin II level].
    Liu F; Wei Y; Yang XZ; Li FG; Hu J; Cheng RF
    Yao Xue Xue Bao; 1992; 27(10):785-7. PubMed ID: 1293928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.